Certara Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Certara's estimated annual revenue is currently $90.7M per year.
- Certara's estimated revenue per employee is $201,000
- Certara has 451 Employees.
- Certara grew their employee count by 8% last year.
- Certara currently has 57 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
|Thermo Fisher S...||$2147.5M||55189||N/A||N/A||4.8/5||N/A|
|Advera Health A...||$2.4M||12||N/A||N/A||-||N/A|
|Olympus Life Sc...||$18.6M||76||10%||N/A||-||N/A|
|De Novo Softwar...||$3.6M||25||N/A||N/A||-||N/A|
|American Gene T...||$4.7M||30||N/A||N/A||-||N/A|
What Is Certara?
Certara is a leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes. Certara's solutions, which span the drug development and patient care lifecycle, help increase the probability of regulatory and commercial success by using the most scientifically advanced modeling and simulation technologies and regulatory strategies. Its clients include hundreds of global biopharmaceutical companies, leading academic institutions and key regulatory agencies. For more information, visit www.certara.com.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
Certara®, the global model-informed drug development and decision support leader, on 30 July 2019, announced the launch of version 19.6 of ...
For example, drug development consultancy Certara is using computer-based modeling and simulation to predict DDIs and simulate different ...
... Growth Opportunities by 2026 with Leading Players like IBM Corporation, Infosys Limited, Thermo Fisher Scientific, Selvita, Certara, L.P., etc.
Certara Executive Hires
|2015-01-21||Gavin Nichols||President Technology/Head Software Business Unit||Article|
|2015-07-17||Tristen Herrstrom||SVP Human Resources||Article|
|2016-02-04||Andrzej Kierzek||Head of Systems Modeling||Article|
|2016-07-25||Nathan Teuscher||VP Pharmacometric Solutions||Article|
|2017-05-16||Sandy Allerheiligen||SVP Health Economics & Education||Article|
|2018-09-06||Mark Holbrook||VP Quantitative Systems Toxicology and Safe||Article|